⌘K
Loading ticker…
Capricor Therapeutics Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Capricor Therapeutics Inc (CAPR) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 77. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.0%, relative volume 5.38×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
24 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
CAPR is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $45M notional. Top 3 carry $112M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $45M |
| XBIState Street SPDR S&P Biotech ETF | 0.48% | $36M |
| IWMiShares Russell 2000 ETF | 0.04% | $32M |
| VXFVanguard Extended Market ETF | 0.02% | $16M |
| IWOiShares Russell 2000 Growth ETF | 0.09% | $11M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CAPR Jan avg: -5.80% median: -4.20% win: 50% σ: 17.50% n: 4 2022-04-12 → 2026-05-29 | CAPR Feb avg: 10.41% median: 5.89% win: 100% σ: 11.69% n: 4 2022-04-12 → 2026-05-29 | CAPR Mar avg: 6.24% median: 0.80% win: 50% σ: 41.81% n: 4 2022-04-12 → 2026-05-29 | CAPR Apr avg: 0.78% median: -7.82% win: 40% σ: 21.89% n: 5 2022-04-12 → 2026-05-29 | CAPR May avg: 1.17% median: 7.78% win: 60% σ: 16.89% n: 5 2022-04-12 → 2026-05-29 | CAPR Jun avg: -3.49% median: -1.73% win: 50% σ: 9.19% n: 4 2022-04-12 → 2026-05-29 (current) | CAPR Jul avg: -2.09% median: -11.42% win: 25% σ: 23.15% n: 4 2022-04-12 → 2026-05-29 | CAPR Aug avg: 15.71% median: 19.40% win: 75% σ: 29.63% n: 4 2022-04-12 → 2026-05-29 | CAPR Sep avg: 50.88% median: 8.95% win: 75% σ: 124.25% n: 4 2022-04-12 → 2026-05-29 | CAPR Oct avg: -0.61% median: -8.52% win: 25% σ: 22.27% n: 4 2022-04-12 → 2026-05-29 | CAPR Nov avg: -9.38% median: -11.62% win: 25% σ: 11.65% n: 4 2022-04-12 → 2026-05-29 | CAPR Dec avg: 115.76% median: 25.50% win: 50% σ: 219.56% n: 4 2022-04-12 → 2026-05-29 |